Abstract
Distribution of intraperitoneally injected /sup 241/Am- and /sup 252/Cf-citrate in the skeleton, liver, and kidneys at 8 and 71 days after ip injection was investigated in rat and in Syrian and Chinese hamsters. The results confirmed that the most obvious difference of radionuclide metabolism among these animal species is the considerably shorter biological half-time in rat liver (several days) compared to that in livers of Syrian and Chinese hamsters (>100 days). Single injections of Ca-DTPA (diethylenetriaminepentaacetate) given 24 hr after radionuclides mobilized similar amounts of /sup 241/Am and /sup 252/Cf from the rat and Chinese hamster livers. In Syrian hamster liver, DTPA effectiveness was markedly lower. On a double logarithmic scale the dose--effect functions for the removal of /sup 252/Cf from liver were linear and, with regard to animal species, parallel to each other. In kidneys, DTPA efficacy increased in the order of rat, Syrian hamster, and Chinese hamster. After 12 Ca-DTPA doses (30 ..mu..moles/kg once weekly, starting 4 days after /sup 252/Cf) chelate efficacy was identical in skeleton of all animal species tested (50% of control removed). From liver and kidneys of Chinese hamster, 94 and 90% of the /sup 252/Cf activity in untreated animals could be mobilized, respectively,more » whereas DTPA effectiveness was considerably lower in liver and kidneys of rat and Syrian hamster. Thus, no relationship has been established between biological half-lives and availability to DTPA of radionuclides.« less
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.